Poly Medicure, a leading player in the healthcare sector, has reported robust consolidated quarterly numbers for March 2024, showcasing significant growth in key financial metrics compared to the same period last year.
According to the reported figures, Poly Medicure’s net sales for March 2024 amounted to Rs 378.07 crore, reflecting a commendable increase of 23.21% from Rs 306.85 crore in March 2023. This substantial growth in net sales indicates the company’s ability to capture market opportunities and expand its revenue base effectively.
Furthermore, the quarterly net profit for March 2024 stood at Rs 68.36 crore, marking a notable rise of 16.23% compared to Rs 58.81 crore in March 2023. The increase in net profit underscores Poly Medicure’s operational efficiency and effective cost management strategies, contributing to bottom-line growth.
The earnings before interest, taxes, depreciation, and amortization (EBITDA) also demonstrated strong performance, reaching Rs 111.55 crore in March 2024, up by 21.63% from Rs 91.71 crore in March 2023. This growth in EBITDA reflects the company’s ability to maintain healthy margins and enhance operational performance across its business segments.
Moreover, Poly Medicure’s earnings per share (EPS) witnessed a significant uptick, reaching Rs 7.12 in March 2024 compared to Rs 6.13 in March 2023. The increase in EPS signifies improved profitability on a per-share basis, which is likely to resonate positively with investors and shareholders.
On the stock market front, Poly Medicure shares closed at Rs 1,641.40 on May 17, 2024, on the National Stock Exchange (NSE). Despite moderate returns of 5.60% over the last six months, the company has delivered impressive returns of 67.47% over the last twelve months, indicating strong investor confidence and market performance.
In conclusion, Poly Medicure’s stellar performance in the latest quarterly report reflects its resilience and agility in navigating dynamic market conditions, positioning the company for sustainable growth and value creation in the healthcare sector.
